Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LME636 in Severe Dry Eye Disease
NCT02365519Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- scFv Fragments
01
Overview
A Phase 2 trial of licaminlimab in dry eye disease (DED), sponsored by Alcon Inc.. Started Mar 2015; status: completed.
02
Drugs
licaminlimab
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02365519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365519.